Vitamin D has a greater impact on cancer mortality rates than on cancer incidence rates

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Grant, William B ^a   Garland, Cedric F ^b  

^a Sunlight   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; HUMAN; LETTER; METASTASIS; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

HUMANS; VITAMIN D DEFICIENCY;

EID: 84899642387     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2862     Document Type: Letter

References (5)

1. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903. (1 April.)
2. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients 2013;5:3993-4023.
3. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014;72:48-54.
4. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
5. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.